speb/financial-data huggingface dataset:
Financial ratios for AET.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 123286250
Buffett classification: The Gruesome
Stock price: 0.00575
Shares outstanding: 275134922
Book value: 123286250
P/B ratio: 0.012832134982611605
Market cap (USD): 1582025.8015
Debt to equity: 0.4278457654442405
Current ratio: 1.0276570914357221
Quick ratio: 0.9227091857538561
Buyback yield (%): 0
Retained earnings: 86507500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AET.L — annual report dated 2024-12-31
Total revenue: 226075000
Gross profit: 108420000
Operating income: 93086250
Net income: 65437500
Capital expenditures: 25761250
Operating cash flow: 106987500
Depreciation & amortization: 16091250
Net tangible assets: 123286250
Owner earnings: 55767500
Return on net tangible assets (%): 45.23416033823723
Capex to operating income (%): 27.67460285487921
Buffett classification: The Good
Stock price: 0.00575
P/E ratio: 0.024176134502387772
Shares outstanding: 275134922
Book value: 123286250
P/B ratio: 0.012832134982611605
Market cap (USD): 1582025.8015
Debt to equity: 0.4278457654442405
Current ratio: 1.0276570914357221
Quick ratio: 0.9227091857538561
Effective tax rate (%): 20.167746854746476
Interest coverage ratio: 9.300487073810416
COGS to revenue (%): 52.042463784142434
SG&A to revenue (%): 6.782594271812452
Free cash flow (dilution-adjusted): 79990000
Buyback yield (%): 0
Retained earnings: 86507500
Inventory turnover: 12.610396570203644
Receivables turnover: 1470.4065040650407
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 47.89403615736364
FCF margin (%): 35.38206347451067
Revenue growth (%): 576.7686623721107
Rule of 40 score: 612.1507258466214
Financial ratios for AET.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 143515068.49315068
Buffett classification: The Gruesome
Stock price: 0.006712328767123288
Shares outstanding: 275134922
Book value: 143515068.49315068
P/B ratio: 0.012868307636065137
Market cap (USD): 1846796.051780822
Debt to equity: 0.3542370616421358
Current ratio: 0.8361688992261417
Quick ratio: 0.48903820476375065
Buyback yield (%): 0
Retained earnings: 102576712.32876712
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALHOP.PA — annual report dated 2021-12-31
Total revenue: 174635227.27272728
Gross profit: 74917045.45454545
Operating income: 5087500
Net income: 5361363.636363637
Capital expenditures: 415909.0909090909
Operating cash flow: 11226136.363636363
Depreciation & amortization: 4402272.7272727275
Net tangible assets: -1682954.5454545454
Owner earnings: 9347727.272727272
Return on net tangible assets (%): -555.4355165428764
Capex to operating income (%): 8.175117266026357
Buffett classification: The Great
Stock price: 8.272727272727273
P/E ratio: 4.731000118694362
Shares outstanding: 3066052
Book value: 25337500
P/B ratio: 1.0010700345337937
Market cap (USD): 25364612.000000004
Debt to equity: 1.8946943535004708
Current ratio: 1.3133714044489264
Quick ratio: 1.3133714044489264
Effective tax rate (%): 31.32513279284317
Interest coverage ratio: 8.383895131086144
COGS to revenue (%): 57.10084006272815
SG&A to revenue (%): 0.6689267889562008
Free cash flow (dilution-adjusted): 9860227.272727273
Buyback yield (%): 0
Retained earnings: 4539772.7272727275
Receivables turnover: 2.947486526400583
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.565950686968718
FCF margin (%): 5.646184579545677
Rule of 40 score: 5.646184579545677
Financial ratios for ALHOP.PA — annual report dated 2022-12-31
Total revenue: 262562765.9574468
Gross profit: 88637234.0425532
Operating income: 10105319.148936171
Net income: 6446808.5106382985
Capital expenditures: 553191.4893617021
Operating cash flow: 9510638.29787234
Depreciation & amortization: 4576595.744680852
Net tangible assets: 836170.2127659575
Owner earnings: 10470212.765957449
Return on net tangible assets (%): 1252.162849872774
Capex to operating income (%): 5.474260448468259
Buffett classification: The Great
Stock price: 13.574468085106384
P/E ratio: 6.4559114719471955
Shares outstanding: 3066052
Book value: 29817021.27659574
P/B ratio: 1.3958478492935638
Market cap (USD): 41620025.0212766
Debt to equity: 1.3710931925217642
Current ratio: 1.2483206332124075
Quick ratio: 1.2483206332124075
Effective tax rate (%): 31.72461116193962
Interest coverage ratio: 14.135416666666668
COGS to revenue (%): 66.24150659011624
SG&A to revenue (%): 0.48255938802879966
Free cash flow (dilution-adjusted): 8207446.808510638
Buyback yield (%): 0
Retained earnings: 5934042.55319149
Receivables turnover: 3.303693094355281
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.549953345228937
FCF margin (%): 3.125898974510654
Revenue growth (%): 50.349256594949985
Rule of 40 score: 53.47515556946064
Financial ratios for ALHOP.PA — annual report dated 2023-12-31
Total revenue: 301525555.5555555
Gross profit: 102795555.55555555
Operating income: 10116666.666666666
Net income: 5762222.222222222
Capital expenditures: 713333.3333333334
Operating cash flow: 15980000
Depreciation & amortization: 4821111.111111111
Net tangible assets: 4376666.666666667
Owner earnings: 9869999.999999998
Return on net tangible assets (%): 225.51408987052545
Capex to operating income (%): 7.051070840197695
Buffett classification: The Great
Stock price: 19.266666666666666
P/E ratio: 10.25170491322792
Shares outstanding: 3066052
Book value: 34985555.55555555
P/B ratio: 1.688485460031124
Market cap (USD): 59072601.86666667
Debt to equity: 1.9364182043382987
Current ratio: 1.170675550620026
Quick ratio: 1.170675550620026
Effective tax rate (%): 27.75532952487112
Interest coverage ratio: 7.735768903993203
COGS to revenue (%): 65.9081780427677
SG&A to revenue (%): 0.52584450184801
Free cash flow (dilution-adjusted): 14418888.888888888
Buyback yield (%): 0
Retained earnings: 5075555.555555555
Receivables turnover: 3.4150432900432897
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.65857843451093
FCF margin (%): 4.781979047289156
Revenue growth (%): 14.8394192360174
Rule of 40 score: 19.621398283306558
Financial ratios for ALHOP.PA — annual report dated 2024-12-31
Total revenue: 332347916.6666667
Gross profit: 108944791.66666667
Operating income: 9204166.666666668
Net income: 5106250
Capital expenditures: 720833.3333333334
Operating cash flow: 6866666.666666667
Depreciation & amortization: 5247916.666666667
Net tangible assets: 5257291.666666667
Owner earnings: 9633333.333333334
Return on net tangible assets (%): 183.23756687140875
Capex to operating income (%): 7.831598008148482
Buffett classification: The Great
Stock price: 17.354166666666668
P/E ratio: 10.420323606691147
Shares outstanding: 3066052
Book value: 35554166.66666666
P/B ratio: 1.4965553240360958
Market cap (USD): 53208777.41666667
Debt to equity: 1.7610160553146612
Current ratio: 1.2191641443937142
Quick ratio: 1.2160861163836592
Effective tax rate (%): 30.424294025826594
Interest coverage ratio: 3.586038961038961
COGS to revenue (%): 67.21965560688787
SG&A to revenue (%): 0.50116908109599
Free cash flow (dilution-adjusted): 5321875
Buyback yield (%): 0
Retained earnings: 5025000
Inventory turnover: 595.7416666666667
Receivables turnover: 4.138237850036965
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.032244879422317
FCF margin (%): 1.6012963322823097
Revenue growth (%): 10.222138901069764
Rule of 40 score: 11.823435233352074
Financial ratios for ALHOP.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 5257291.666666667
Buffett classification: The Gruesome
Stock price: 17.354166666666668
Shares outstanding: 3066052
Book value: 35554166.66666666
P/B ratio: 1.4965553240360958
Market cap (USD): 53208777.41666667
Debt to equity: 1.7610160553146612
Current ratio: 1.2191641443937142
Quick ratio: 1.2160861163836592
Buyback yield (%): 0
Retained earnings: 5025000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARKO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.1
Shares outstanding: 112185721
Market cap (USD): 908704340.0999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARKO — annual report dated 2022-12-31
Total revenue: 9142799000
Gross profit: 418551000
Operating income: 167014000
Net income: 71978000
Capital expenditures: 189306000
Operating cash flow: 209256000
Depreciation & amortization: 101752000
Net tangible assets: -33586000
Owner earnings: -15576000
Capex to operating income (%): 113.34738405163638
Buffett classification: The Gruesome
Stock price: 8.07
P/E ratio: 12.577992837672621
Shares outstanding: 112185721
Book value: 380890000
P/B ratio: 2.376903485179448
Market cap (USD): 905338768.47
Debt to equity: 5.93073853343485
Current ratio: 1.673568815785642
Quick ratio: 1.1764012803770347
Effective tax rate (%): 33.0427752325549
Interest coverage ratio: 2.6686799929693366
COGS to revenue (%): 95.42206932472212
SG&A to revenue (%): 1.530920673198656
Free cash flow (dilution-adjusted): 98324000
Buyback yield (%): 4.422874772906278
Retained earnings: 81750000
Inventory turnover: 39.30709030371568
Receivables turnover: 55.78789395002593
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.946227114730133
FCF margin (%): 1.0754255890346054
Rule of 40 score: 1.0754255890346054
Financial ratios for ARKO — annual report dated 2023-12-31
Total revenue: 9412731000
Gross profit: 423634000
Operating income: 118014000
Net income: 34566000
Capital expenditures: 199076000
Operating cash flow: 136094000
Depreciation & amortization: 127597000
Net tangible assets: -130624000
Owner earnings: -36913000
Capex to operating income (%): 168.68846069110444
Buffett classification: The Gruesome
Stock price: 7.81
P/E ratio: 25.347754469999423
Shares outstanding: 112185721
Book value: 376117000
P/B ratio: 2.3295157650677845
Market cap (USD): 876170481.01
Debt to equity: 6.725944320517286
Current ratio: 1.5406746684655632
Quick ratio: 1.025288755799796
Effective tax rate (%): 26.01184494665498
Interest coverage ratio: 1.2895449975960487
COGS to revenue (%): 95.49935082602488
SG&A to revenue (%): 1.7560684566466416
Free cash flow (dilution-adjusted): 9870000
Buyback yield (%): 3.8455986283810266
Retained earnings: 96097000
Inventory turnover: 35.871301273379544
Receivables turnover: 46.999266005572366
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.729733829729405
FCF margin (%): 0.10485798436181805
Revenue growth (%): 2.9524000254189118
Rule of 40 score: 3.05725800978073
Financial ratios for ARKO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.74
Shares outstanding: 112185721
Market cap (USD): 756131759.5400001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARKO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.36
Shares outstanding: 112185721
Market cap (USD): 713501185.5600001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARKO — annual report dated 2024-12-31
Total revenue: 8731962000
Gross profit: 397218000
Operating income: 94026000
Net income: 20845000
Capital expenditures: 60365000
Operating cash flow: 221858000
Depreciation & amortization: 132414000
Net tangible assets: -105462000
Owner earnings: 92894000
Return on net tangible assets (%): -88.08291138040242
Capex to operating income (%): 64.20032756897028
Buffett classification: The Good
Stock price: 6.36
P/E ratio: 34.22888872919165
Shares outstanding: 112185721
Book value: 376866000
P/B ratio: 1.893249021031348
Market cap (USD): 713501185.5600001
Debt to equity: 6.855057235197656
Current ratio: 1.6211542346629555
Quick ratio: 1.102119015017172
Effective tax rate (%): 22.869905080960358
Interest coverage ratio: 0.9618831328259269
COGS to revenue (%): 95.45098799101508
SG&A to revenue (%): 1.8657891548314112
Free cash flow (dilution-adjusted): 98286000
Buyback yield (%): 4.48338428125989
Retained earnings: 97177000
Inventory turnover: 36.0460330846578
Receivables turnover: 58.805446868118175
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.961292126904781
FCF margin (%): 1.1255889569835509
Revenue growth (%): -7.232428080649495
Rule of 40 score: -6.106839123665944
Financial ratios for ARKO — quarterly report dated 2025-03-31
Total revenue: 1829473000
Gross profit: 66953000
Operating income: -11764000
Net income: -12672000
Capital expenditures: 26919000
Operating cash flow: 43402000
Depreciation & amortization: 34887000
Net tangible assets: -121502000
Owner earnings: -4704000
Buffett classification: The Gruesome
Stock price: 3.84
Shares outstanding: 112185721
Book value: 355226000
P/B ratio: 1.212729835766526
Market cap (USD): 430793168.64
Debt to equity: 7.220189400550636
Current ratio: 1.55364406358615
Quick ratio: 1.07700715657409
Interest coverage ratio: -0.504329932264426
COGS to revenue (%): 96.34031221012827
SG&A to revenue (%): 2.2745894582756896
Free cash flow (dilution-adjusted): 12674000
Buyback yield (%): 1.7135833475040316
Retained earnings: 79592000
Inventory turnover: 7.987854067527759
Receivables turnover: 16.62462061319812
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.37469454941101227
FCF margin (%): 0.6927678079971664
Rule of 40 score: 0.6927678079971664
Financial ratios for ARKO — quarterly report dated 2025-06-30
Total revenue: 1999519000
Gross profit: 316232000
Operating income: 39435000
Net income: 20098000
Capital expenditures: 43544000
Operating cash flow: 55185000
Depreciation & amortization: 33602000
Net tangible assets: -106288000
Owner earnings: 10156000
Return on net tangible assets (%): -9.55517085654072
Capex to operating income (%): 110.41967795105872
Buffett classification: The Gruesome
Stock price: 4.14
P/E ratio: 62.54361499326689
Shares outstanding: 112185721
Book value: 364835000
P/B ratio: 1.2730381814792988
Market cap (USD): 464448884.93999994
Debt to equity: 7.150188441350199
Current ratio: 1.5455698255038022
Quick ratio: 1.1148589936013904
Effective tax rate (%): 46.002367373291726
Interest coverage ratio: 1.69824727617243
COGS to revenue (%): 84.1845963954331
SG&A to revenue (%): 2.037590040404717
Free cash flow (dilution-adjusted): 6180000
Buyback yield (%): 1.9827800859484612
Retained earnings: 94842000
Inventory turnover: 8.12436411023698
Receivables turnover: 17.798023944100763
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2607983937489209
FCF margin (%): 0.30907433237693666
Revenue growth (%): 9.294807849036307
Rule of 40 score: 9.603882181413244
Financial ratios for ARKO — quarterly report dated 2025-09-30
Total revenue: 2020833000
Gross profit: 110919000
Operating income: 37927000
Net income: 13459000
Capital expenditures: 23310000
Operating cash flow: 49422000
Depreciation & amortization: 32944000
Net tangible assets: -92428000
Owner earnings: 23093000
Return on net tangible assets (%): -24.98485307482581
Capex to operating income (%): 61.46017349118043
Buffett classification: The Good
Stock price: 4.5
P/E ratio: 24.172168757481444
Shares outstanding: 112185721
Book value: 373126000
P/B ratio: 1.352989993996666
Market cap (USD): 504835744.5
Debt to equity: 6.945026612994002
Current ratio: 1.6174528929950478
Quick ratio: 1.183020432005704
Effective tax rate (%): 15.007288167817986
Interest coverage ratio: 1.6149457100276772
COGS to revenue (%): 94.5112238369029
SG&A to revenue (%): 1.9817570279186851
Free cash flow (dilution-adjusted): 20636000
Buyback yield (%): 0.8283882521317784
Retained earnings: 103473000
Inventory turnover: 9.441465223194424
Receivables turnover: 17.988063341730236
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2150863314561493
FCF margin (%): 1.0211630550372048
Revenue growth (%): 1.0659563625051824
Rule of 40 score: 2.0871194175423873
Financial ratios for ARKO — quarterly report dated 2025-12-31
Total revenue: 1794214000
Gross profit: 103852000
Operating income: 34487000
Net income: 1859000
Capital expenditures: 26315000
Operating cash flow: 44576000
Depreciation & amortization: 33018000
Net tangible assets: -92870000
Owner earnings: 8562000
Return on net tangible assets (%): -9.219338860773124
Capex to operating income (%): 76.30411459390494
Buffett classification: The Gruesome
Stock price: 4.5
P/E ratio: 22.196436180970807
Shares outstanding: 112185721
Book value: 367239000
P/B ratio: 1.3746790087654088
Market cap (USD): 504835744.5
Debt to equity: 7.0181489438757865
Current ratio: 1.6574649045222882
Quick ratio: 1.2170665976957875
Effective tax rate (%): -12.423873325213155
Interest coverage ratio: 1.503094490934449
COGS to revenue (%): 94.21183872157948
SG&A to revenue (%): 2.4137588938666177
Free cash flow (dilution-adjusted): 10554000
Buyback yield (%): 1.4244237018363506
Retained earnings: 100549000
Inventory turnover: 8.863659960043417
Receivables turnover: 12.171094046779183
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.111845814933946
FCF margin (%): 0.588224147175309
Revenue growth (%): -11.214137932228937
Rule of 40 score: -10.625913785053628
Financial ratios for ARKO — annual report dated 2025-12-31
Total revenue: 7643471000
Gross profit: 395503000
Operating income: 102302000
Net income: 22744000
Capital expenditures: 120088000
Operating cash flow: 192585000
Depreciation & amortization: 134451000
Net tangible assets: -92870000
Owner earnings: 37107000
Return on net tangible assets (%): -39.955852266609234
Capex to operating income (%): 117.38577935915231
Buffett classification: The Gruesome
Stock price: 4.5
P/E ratio: 22.196436180970807
Shares outstanding: 112185721
Book value: 367239000
P/B ratio: 1.3746790087654088
Market cap (USD): 504835744.5
Debt to equity: 7.0181489438757865
Current ratio: 1.6574649045222882
Quick ratio: 1.2170665976957875
Effective tax rate (%): 21.885568362205813
Interest coverage ratio: 1.1017392709062517
COGS to revenue (%): 94.82560998792302
SG&A to revenue (%): 2.1680071789374225
Free cash flow (dilution-adjusted): 50044000
Buyback yield (%): 5.53922742291082
Retained earnings: 100549000
Inventory turnover: 38.00577849790516
Receivables turnover: 51.849670320725025
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2981717910915
FCF margin (%): 0.6547287220688088
Revenue growth (%): -12.465594788433574
Rule of 40 score: -11.810866066364765
Financial ratios for ASCE.BR — annual report dated 2021-09-30
Capital expenditures: 0
Depreciation & amortization: 95348.83720930232
Buffett classification: The Gruesome
Stock price: 37.83720930232558
Shares outstanding: 6907188
Market cap (USD): 261348718.04651165
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASCE.BR — annual report dated 2022-09-30
Total revenue: 53454901.960784316
Gross profit: 43881372.549019605
Operating income: 39622549.01960784
Net income: 88875490.19607843
Capital expenditures: 23529.41176470588
Operating cash flow: 38139215.686274506
Depreciation & amortization: 34313.72549019608
Net tangible assets: 428418627.45098037
Owner earnings: 88886274.50980392
Return on net tangible assets (%): 20.74752795849762
Capex to operating income (%): 0.05938389211926265
Buffett classification: The Great
Stock price: 35.431372549019606
P/E ratio: 2.753640522872933
Shares outstanding: 6907188
Book value: 428442156.86274505
P/B ratio: 0.5712116498669371
Market cap (USD): 244731151.29411763
Debt to equity: 0.7476127603195343
Current ratio: 0.18566789411116585
Quick ratio: 0.18566789411116585
Effective tax rate (%): 5.595301321503328
Interest coverage ratio: 10.632728229413312
COGS to revenue (%): 17.909544420805513
SG&A to revenue (%): 1.3663707725038514
Free cash flow (dilution-adjusted): 38092156.8627451
Buyback yield (%): 0
Retained earnings: 88875490.19607843
Receivables turnover: 14.512643066276285
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.657717538294412
FCF margin (%): 71.26036240921428
Rule of 40 score: 71.26036240921428
Financial ratios for ASCE.BR — annual report dated 2023-09-30
Total revenue: 62301052.63157895
Gross profit: 49356842.10526316
Operating income: 44928421.05263158
Net income: 35585263.15789474
Capital expenditures: 40000
Operating cash flow: 45728421.05263158
Depreciation & amortization: 25263.157894736843
Net tangible assets: 467923157.8947369
Owner earnings: 35570526.315789476
Return on net tangible assets (%): 7.601787967884965
Capex to operating income (%): 0.08903050466238696
Buffett classification: The Great
Stock price: 33.38947368421053
P/E ratio: 6.480979807134829
Shares outstanding: 6907188
Book value: 468171578.9473685
P/B ratio: 0.4926129272443975
Market cap (USD): 230627371.95789474
Debt to equity: 0.7206062554663943
Current ratio: 0.20895288331313708
Quick ratio: 0.20895288331313708
Effective tax rate (%): 0.754484337844582
Interest coverage ratio: 4.305659235347523
COGS to revenue (%): 20.776872909133914
SG&A to revenue (%): 1.3313959382286351
Free cash flow (dilution-adjusted): 45465263.15789474
Buyback yield (%): 0
Retained earnings: 35585263.15789474
Receivables turnover: 13.805924889199906
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.958476890345708
FCF margin (%): 72.97671746696854
Revenue growth (%): 16.548810953360956
Rule of 40 score: 89.5255284203295
Financial ratios for ASCE.BR — quarterly report dated 2024-09-30
Total revenue: 22488888.888888888
Gross profit: 12681111.11111111
Operating income: 11614444.444444444
Net income: 5052222.222222222
Capital expenditures: 0
Net tangible assets: 491717777.7777778
Owner earnings: 5052222.222222222
Return on net tangible assets (%): 1.0274638116715549
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 45.355555555555554
P/E ratio: 15.502057079393007
Shares outstanding: 6907188
Book value: 492134444.4444445
P/B ratio: 0.6365726939115552
Market cap (USD): 313279349.06666666
Debt to equity: 0.7036717608783507
Current ratio: 0.11214369928566474
Quick ratio: 0.11214369928566474
Effective tax rate (%): 11.260733801717409
Interest coverage ratio: 1.2173052288342845
COGS to revenue (%): 43.61166007905138
Buyback yield (%): 0
Retained earnings: 28352222.22222222
Receivables turnover: 4.304551254785198
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6059623252576867
Rule of 40 score: 0
Financial ratios for ASCE.BR — annual report dated 2024-09-30
Total revenue: 67497777.77777778
Gross profit: 53581111.11111111
Operating income: 48370000
Net income: 28352222.22222222
Capital expenditures: 1046666.6666666666
Operating cash flow: 48370000
Depreciation & amortization: 132222.22222222222
Net tangible assets: 491717777.7777778
Owner earnings: 27437777.777777776
Return on net tangible assets (%): 5.579984905523945
Capex to operating income (%): 2.1638756805182275
Buffett classification: The Great
Stock price: 45.355555555555554
P/E ratio: 11.0495518344633
Shares outstanding: 6907188
Book value: 492134444.4444445
P/B ratio: 0.6365726939115552
Market cap (USD): 313279349.06666666
Debt to equity: 0.7036717608783507
Current ratio: 0.11214369928566474
Quick ratio: 0.11214369928566474
Effective tax rate (%): 2.3048355603200736
Interest coverage ratio: 3.2258614301593185
COGS to revenue (%): 20.617962731283335
SG&A to revenue (%): 1.2263778231382103
Free cash flow (dilution-adjusted): 47066666.666666664
Buyback yield (%): 0
Retained earnings: 28352222.22222222
Receivables turnover: 12.919608677158656
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.688257716009077
FCF margin (%): 69.7306907223283
Revenue growth (%): 8.341311946894338
Rule of 40 score: 78.07200266922264
Financial ratios for ASCE.BR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 41.29166666666667
Shares outstanding: 6907188
Market cap (USD): 285209304.50000006
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASCE.BR — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 470550000
Buffett classification: The Gruesome
Stock price: 44.391304347826086
Shares outstanding: 6907188
Book value: 470944565.21739125
P/B ratio: 0.6510725621265311
Market cap (USD): 306619084.6956522
Debt to equity: 0.7438173513452382
Current ratio: 0.19138766844907645
Quick ratio: 0.19138766844907645
Buyback yield (%): 0
Retained earnings: 20301086.95652174
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASCE.BR — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 529100000
Buffett classification: The Gruesome
Stock price: 55.576470588235296
P/E ratio: 75.98183805948331
Shares outstanding: 6907188
Book value: 529640000.00000006
P/B ratio: 0.7247887824360165
Market cap (USD): 383877130.7294118
Debt to equity: 0.6604330577484373
Current ratio: 0.13787653622060247
Quick ratio: 0.13787653622060247
Buyback yield (%): 0
Retained earnings: 41925882.35294118
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASCE.BR — annual report dated 2025-09-30
Total revenue: 72060000
Gross profit: 57563529.4117647
Operating income: 51989411.76470588
Net income: 41925882.35294118
Capital expenditures: 76470.58823529413
Operating cash flow: 54098823.52941176
Depreciation & amortization: 212941.17647058825
Net tangible assets: 529100000
Owner earnings: 42062352.94117647
Return on net tangible assets (%): 7.949792655675007
Capex to operating income (%): 0.14708877373220794
Buffett classification: The Great
Stock price: 55.576470588235296
P/E ratio: 9.156089489014226
Shares outstanding: 6907188
Book value: 529640000.00000006
P/B ratio: 0.7247887824360165
Market cap (USD): 383877130.7294118
Debt to equity: 0.6604330577484373
Current ratio: 0.13787653622060247
Quick ratio: 0.13787653622060247
Effective tax rate (%): 2.176777381279166
Interest coverage ratio: 4.149779322002066
COGS to revenue (%): 20.117222575957943
SG&A to revenue (%): 1.9624169401315898
Free cash flow (dilution-adjusted): 53929411.76470588
Buyback yield (%): 0
Retained earnings: 41925882.35294118
Receivables turnover: 13.405778069599474
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.415715606865923
FCF margin (%): 74.83959445560072
Revenue growth (%): 6.759070257457038
Rule of 40 score: 81.59866471305776
Financial ratios for ASCE.BR — quarterly report dated 2025-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 57.847058823529416
Shares outstanding: 6907188
Market cap (USD): 399560510.5411765
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASND — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 134.53
Shares outstanding: 65592830
Market cap (USD): 8824203419.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASND — annual report dated 2022-12-31
Total revenue: 7342037.302725969
Gross profit: 5600717.360114777
Operating income: -80604591.10473458
Net income: -83672022.95552367
Capital expenditures: 710760.4017216644
Operating cash flow: -71118938.30703013
Depreciation & amortization: 2576470.588235294
Net tangible assets: 37090387.37446198
Owner earnings: -81806312.76901005
Return on net tangible assets (%): -220.55933776883805
Buffett classification: The Gruesome
Stock price: 122.13
Shares outstanding: 65592830
Book value: 37783070.30129126
P/B ratio: 212.02226986900598
Market cap (USD): 8010852327.9
Debt to equity: 1.930438051551559
Current ratio: 1.2883658376315088
Quick ratio: 1.106059485725686
Interest coverage ratio: -18.31086630597745
COGS to revenue (%): 23.717121976003437
R&D to revenue (%): 741.8298354633213
SG&A to revenue (%): 421.79622464532764
Free cash flow (dilution-adjusted): -82405738.88091822
Buyback yield (%): 0.18859817606064877
Inventory turnover: 0.09288070221086224
Receivables turnover: 1.996956216342777
Capitalized R&D asset: 54465423.242467724
ROCI (R&D-adjusted, %): -41.02278590901139
FCF margin (%): -1122.382459842889
Rule of 40 score: -1122.382459842889
Financial ratios for ASND — annual report dated 2023-12-31
Total revenue: 39631203.56612184
Gross profit: 33034621.099554233
Operating income: -67688112.92719167
Net income: -71537444.27934621
Capital expenditures: 355274.8885586924
Operating cash flow: -69444427.9346211
Depreciation & amortization: 2809955.4234769684
Net tangible assets: -22305497.771173846
Owner earnings: -69082763.74442793
Buffett classification: The Gruesome
Stock price: 125.95
Shares outstanding: 65592830
Book value: -21648885.58692421
Market cap (USD): 8261416938.5
Debt to equity: -4.421951035367923
Current ratio: 0.9541241179673297
Quick ratio: 0.670446661208485
Interest coverage ratio: -10.337932599568818
COGS to revenue (%): 16.64492085273585
R&D to revenue (%): 155.01540953366478
SG&A to revenue (%): 99.134666576684
Free cash flow (dilution-adjusted): -79712184.24962851
Buyback yield (%): 0
Inventory turnover: 0.21248641896128387
Receivables turnover: 4.782206443978269
Capitalized R&D asset: 97926306.08359751
ROCI (R&D-adjusted, %): -40.3796551024094
Rosenberg metric: 0.5036939420687128
FCF margin (%): -201.13490653049286
Revenue growth (%): 439.78482990555597
Rule of 40 score: 238.6499233750631
Financial ratios for ASND — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 149.31
Shares outstanding: 65592830
Market cap (USD): 9793665447.3
Buyback yield (%): 0
Retained earnings: -381354341.3173653
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASND — quarterly report dated 2024-12-31
Capital expenditures: 53417.01534170153
Depreciation & amortization: 607531.3807531381
Buffett classification: The Gruesome
Stock price: 137.67
Shares outstanding: 65592830
Market cap (USD): 9030164906.099998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASND — annual report dated 2024-12-31
Total revenue: 50717015.34170154
Gross profit: 44544351.464435145
Operating income: -38879079.49790795
Net income: -52731380.75313807
Capital expenditures: 66527.19665271966
Operating cash flow: -42705299.86052999
Depreciation & amortization: 2470571.827057183
Net tangible assets: -15304602.510460252
Owner earnings: -50327336.12273361
Buffett classification: The Gruesome
Stock price: 137.67
Shares outstanding: 65592830
Book value: -14742817.294281721
Market cap (USD): 9030164906.099998
Debt to equity: -8.103759483851443
Current ratio: 1.1685254272946468
Quick ratio: 0.8429157262714748
Interest coverage ratio: -4.255663776257938
COGS to revenue (%): 12.170794822366013
R&D to revenue (%): 84.42502358094933
SG&A to revenue (%): 78.12100395719955
Free cash flow (dilution-adjusted): -56225383.54253835
Buyback yield (%): 0
Inventory turnover: 0.14971803970785735
Receivables turnover: 2.0493744364292157
Capitalized R&D asset: 101952538.41426614
ROCI (R&D-adjusted, %): -35.01728674319032
Rosenberg metric: 0.18734970602690637
FCF margin (%): -110.86098652242183
Revenue growth (%): 27.97243277531002
Rule of 40 score: -82.88855374711181
Financial ratios for ASND — quarterly report dated 2025-03-31
Total revenue: 14652249.637155298
Gross profit: 12109869.375907112
Operating income: -15125108.853410741
Net income: -13733817.126269957
Capital expenditures: 0
Operating cash flow: -2077358.4905660378
Depreciation & amortization: 659651.6690856314
Net tangible assets: -28115529.753265604
Owner earnings: -13074165.457184326
Buffett classification: The Gruesome
Stock price: 155.86
Shares outstanding: 65592830
Book value: -27548185.77648765
Market cap (USD): 10223298483.800001
Debt to equity: -4.463860658458331
Current ratio: 1.0406309146840005
Quick ratio: 0.7096672192684877
Interest coverage ratio: -2.3268878667440718
COGS to revenue (%): 17.351467004774452
R&D to revenue (%): 85.78461477504607
SG&A to revenue (%): 100.091130613943
Free cash flow (dilution-adjusted): -5786792.452830189
Buyback yield (%): 0.02469671194330903
Retained earnings: -385717416.54571843
Inventory turnover: 0.05977049929880473
Receivables turnover: 1.3141458715715755
Capitalized R&D asset: 12569375.907111757
ROCI (R&D-adjusted, %): -17.703171283864
FCF margin (%): -39.49422509261644
Rule of 40 score: -39.49422509261644
Financial ratios for ASND — quarterly report dated 2025-06-30
Total revenue: 24849842.767295595
Gross profit: 19905345.911949683
Operating income: -8325628.93081761
Net income: -6109276.729559748
Capital expenditures: 682075.4716981131
Operating cash flow: -1154245.283018868
Depreciation & amortization: 677358.4905660377
Net tangible assets: -30088364.779874213
Owner earnings: -6113993.710691824
Buffett classification: The Gruesome
Stock price: 172.6
Shares outstanding: 65592830
Book value: -29492452.83018866
Market cap (USD): 11321322458
Debt to equity: -4.225225513402855
Current ratio: 1.0192053475935827
Quick ratio: 0.6947336898395722
Interest coverage ratio: -1.603701011569447
COGS to revenue (%): 19.89749754816666
R&D to revenue (%): 45.549052485051725
SG&A to revenue (%): 66.88601347717422
Free cash flow (dilution-adjusted): -6667295.597484277
Buyback yield (%): 0
Retained earnings: -419249528.3018868
Inventory turnover: 0.1036551399065861
Receivables turnover: 1.3037972595055232
Capitalized R&D asset: 19740349.78229318
ROCI (R&D-adjusted, %): -11.350693490716152
Rosenberg metric: 0.6201959901312115
FCF margin (%): -26.83033313296846
Revenue growth (%): 69.59745692757755
Rule of 40 score: 42.76712379460909
Financial ratios for ASND — quarterly report dated 2025-09-30
Total revenue: 33590251.57232704
Gross profit: 30075471.698113207
Operating income: 1729088.0503144653
Net income: -9589465.408805031
Capital expenditures: 8333.333333333332
Operating cash flow: 338522.0125786163
Depreciation & amortization: 631918.2389937106
Net tangible assets: -27958647.798742138
Owner earnings: -8965880.503144655
Capex to operating income (%): 0.4819496226243521
Buffett classification: The Great
Stock price: 198.81
Shares outstanding: 65592830
Book value: -27370283.01886794
Market cap (USD): 13040510532.3
Debt to equity: -4.674134712049401
Current ratio: 1.0317258059938124
Quick ratio: 0.725565746631471
Interest coverage ratio: 0.557628923482582
COGS to revenue (%): 10.46369023657283
R&D to revenue (%): 31.30541018751697
SG&A to revenue (%): 52.27959968918806
Free cash flow (dilution-adjusted): -4486792.452830189
Buyback yield (%): 0
Inventory turnover: 0.074014475766666
Receivables turnover: 1.4508251273344652
Capitalized R&D asset: 22247101.59651669
ROCI (R&D-adjusted, %): 1.5947707551619839
Rosenberg metric: 0.8985108629215983
FCF margin (%): -13.357424380014418
Revenue growth (%): 35.17289379607074
Rule of 40 score: 21.81546941605632
Financial ratios for ASND — quarterly report dated 2025-12-31
Total revenue: 38915094.33962264
Gross profit: 35204716.981132075
Operating income: 1012893.0817610063
Net income: -5277044.025157233
Capital expenditures: 533176.1006289308
Operating cash flow: 11540566.037735848
Depreciation & amortization: 758490.5660377358
Net tangible assets: -26184119.496855345
Owner earnings: -5051729.559748428
Capex to operating income (%): 52.638932008692954
Buffett classification: The Good
Stock price: 213.24
Shares outstanding: 65592830
Book value: -25600786.163522005
Market cap (USD): 13987015069.2
Debt to equity: -5.354260199851372
Current ratio: 1.0370248113178435
Quick ratio: 0.7550577852254227
Interest coverage ratio: 0.3136624793066511
COGS to revenue (%): 9.534545454545453
R&D to revenue (%): 31.57616161616162
SG&A to revenue (%): 54.544646464646476
Free cash flow (dilution-adjusted): 6297484.27672956
Buyback yield (%): 0
Inventory turnover: 0.0782600909353205
Receivables turnover: 1.5694754464285714
Capitalized R&D asset: 23068548.742138363
ROCI (R&D-adjusted, %): 3.225540645264842
Rosenberg metric: 0.48777643206387666
FCF margin (%): 16.182626262626265
Revenue growth (%): 15.852345600419415
Rule of 40 score: 32.03497186304568
Financial ratios for ASND — annual report dated 2025-12-31
Total revenue: 113228301.88679245
Gross profit: 98304559.74842767
Operating income: -21426257.86163522
Net income: -35854402.515723266
Capital expenditures: 1334119.4968553458
Operating cash flow: 8474371.06918239
Depreciation & amortization: 2782389.937106918
Net tangible assets: -26184119.496855345
Owner earnings: -34406132.07547169
Buffett classification: The Gruesome
Stock price: 213.24
Shares outstanding: 65592830
Book value: -25600786.163522005
Market cap (USD): 13987015069.2
Debt to equity: -5.354260199851372
Current ratio: 1.0370248113178435
Quick ratio: 0.7550577852254227
Interest coverage ratio: -1.689721874341265
COGS to revenue (%): 13.18022251476118
R&D to revenue (%): 42.1618536601623
SG&A to revenue (%): 62.21692689673559
Free cash flow (dilution-adjusted): -11125628.930817608
Buyback yield (%): 0.019555424172018186
Inventory turnover: 0.3147748339319411
Receivables turnover: 4.566583806818182
Capitalized R&D asset: 96700487.82046989
ROCI (R&D-adjusted, %): -18.259019703527986
Rosenberg metric: 1.2555559321579732
FCF margin (%): -9.825837485349906
Revenue growth (%): 123.25505774329677
Rule of 40 score: 113.42922025794687
Financial ratios for AUPH — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 1651968.5039370079
Buffett classification: The Gruesome
Stock price: 22.87
Shares outstanding: 128601671
Market cap (USD): 2941120215.77
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AUPH — annual report dated 2022-12-31
Total revenue: 98551470.58823529
Gross profit: 94386764.70588234
Operating income: -81963235.29411764
Net income: -79544117.64705881
Capital expenditures: 214705.88235294117
Operating cash flow: -58477205.88235293
Depreciation & amortization: 1989705.882352941
Net tangible assets: 293389705.88235295
Owner earnings: -77769117.64705881
Return on net tangible assets (%): -26.50710508508558
Buffett classification: The Gruesome
Stock price: 4.32
Shares outstanding: 128601671
Book value: 298113970.58823526
P/B ratio: 1.8635799510629327
Market cap (USD): 555559218.72
Debt to equity: 0.019948943727107923
Current ratio: 9.59808705836424
Quick ratio: 9.061248834233412
COGS to revenue (%): 4.225919570245467
R&D to revenue (%): 33.56561963739461
SG&A to revenue (%): 146.51272103260465
Free cash flow (dilution-adjusted): -82441911.76470588
Buyback yield (%): 0
Retained earnings: -635516176.4705882
Inventory turnover: 0.22882999353587585
Receivables turnover: 9.940666023881926
Capitalized R&D asset: 33079411.76470588
ROCI (R&D-adjusted, %): -17.345303049978604
FCF margin (%): -83.6536596284414
Rule of 40 score: -83.6536596284414
Financial ratios for AUPH — annual report dated 2023-12-31
Total revenue: 132964393.93939394
Gross profit: 122246212.12121211
Operating income: -69462878.78787878
Net income: -59106060.6060606
Capital expenditures: 543939.3939393939
Operating cash flow: -25349242.424242422
Depreciation & amortization: 8823484.848484848
Net tangible assets: 282558333.3333333
Owner earnings: -50826515.15151514
Return on net tangible assets (%): -17.987972448703268
Buffett classification: The Gruesome
Stock price: 8.99
Shares outstanding: 128601671
Book value: 286328787.8787879
P/B ratio: 4.0377673193637325
Market cap (USD): 1156129022.29
Debt to equity: 0.2582510040904449
Current ratio: 5.503446131523035
Quick ratio: 4.989052702492616
Interest coverage ratio: -33.0418018018018
COGS to revenue (%): 8.060941354771442
R&D to revenue (%): 28.28337502065374
SG&A to revenue (%): 111.12339256921138
Free cash flow (dilution-adjusted): -60219696.96969697
Buyback yield (%): 0
Retained earnings: -713880303.030303
Inventory turnover: 0.35632791839818667
Receivables turnover: 7.2860226659471135
Capitalized R&D asset: 59770024.06417112
ROCI (R&D-adjusted, %): -13.305906783975352
Rosenberg metric: 0.8421989971736571
FCF margin (%): -45.290092471782714
Revenue growth (%): 34.918731446374515
Rule of 40 score: -10.371361025408198
Financial ratios for AUPH — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 2020740.7407407407
Buffett classification: The Gruesome
Stock price: 7.33
Shares outstanding: 128601671
Market cap (USD): 942650248.4300001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AUPH — annual report dated 2024-12-31
Total revenue: 164428671.32867134
Gross profit: 144674825.1748252
Operating income: 12880419.580419581
Net income: 4022377.6223776224
Capital expenditures: 196503.4965034965
Operating cash flow: 31040559.440559443
Depreciation & amortization: 13597902.097902099
Net tangible assets: 260925174.82517484
Owner earnings: 17423776.223776225
Return on net tangible assets (%): 6.677690734690706
Capex to operating income (%): 1.5255985666974319
Buffett classification: The Great
Stock price: 8.98
P/E ratio: 287.10457197138385
Shares outstanding: 128601671
Book value: 263970629.3706294
P/B ratio: 4.374892041335918
Market cap (USD): 1154843005.5800002
Debt to equity: 0.210261260258876
Current ratio: 4.568149504413735
Quick ratio: 4.1668934054806
Effective tax rate (%): 22.771213748657356
Interest coverage ratio: 3.8095139607032062
COGS to revenue (%): 12.013626330629899
R&D to revenue (%): 8.839677969489609
SG&A to revenue (%): 73.16199767790995
Free cash flow (dilution-adjusted): 8748951.048951048
Buyback yield (%): 2.436622181820154
Retained earnings: -654944055.9440559
Inventory turnover: 0.7200978892627715
Receivables turnover: 6.434243651488616
Capitalized R&D asset: 50647739.09913616
ROCI (R&D-adjusted, %): -0.26995633430887217
Rosenberg metric: 0.5963975188003721
FCF margin (%): 5.320818430420229
Revenue growth (%): 23.663686538231453
Rule of 40 score: 28.98450496865168
Financial ratios for AUPH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.98
Shares outstanding: 128601671
Market cap (USD): 1154843005.5800002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AUPH — quarterly report dated 2025-03-31
Total revenue: 43681818.18181819
Gross profit: 37686013.986013986
Operating income: 16349650.34965035
Net income: 16324475.524475526
Capital expenditures: 11888.11188811189
Operating cash flow: 909090.9090909092
Depreciation & amortization: 3395804.195804196
Net tangible assets: 241980419.5804196
Owner earnings: 19708391.608391613
Return on net tangible assets (%): 8.144622462662413
Capex to operating income (%): 0.07271171941830626
Buffett classification: The Great
Stock price: 8.04
P/E ratio: 15.834466370600579
Shares outstanding: 128601671
Book value: 244888111.8881119
P/B ratio: 4.222162631203632
Market cap (USD): 1033957434.8399999
Debt to equity: 0.2224792255632657
Current ratio: 5.931672660292957
Quick ratio: 5.256366400608134
Effective tax rate (%): 4.127479567949402
Interest coverage ratio: 21.91190253045923
COGS to revenue (%): 13.72608660850076
R&D to revenue (%): 9.193948611222282
SG&A to revenue (%): 32.56063395501481
Free cash flow (dilution-adjusted): 3281118.881118881
Buyback yield (%): 3.173427358444944
Retained earnings: -638619580.4195805
Inventory turnover: 0.18560450265180214
Receivables turnover: 1.5480793060718712
Capitalized R&D asset: 4016083.916083916
ROCI (R&D-adjusted, %): 6.153203659688472
FCF margin (%): 7.5114063875770425
Rule of 40 score: 7.5114063875770425
Financial ratios for AUPH — quarterly report dated 2025-06-30
Total revenue: 51100729.927007295
Gross profit: 45907299.27007299
Operating income: 14742335.766423356
Net income: 15702919.708029196
Capital expenditures: 71532.84671532846
Operating cash flow: 32292700.729927003
Depreciation & amortization: 3550364.9635036495
Net tangible assets: 241791970.8029197
Owner earnings: 19181751.82481752
Return on net tangible assets (%): 7.933163273007201
Capex to operating income (%): 0.4852205773134624
Buffett classification: The Great
Stock price: 8.47
P/E ratio: 34.010138678543235
Shares outstanding: 128601671
Book value: 244745255.4744525
P/B ratio: 4.450571069328456
Market cap (USD): 1089256153.3700001
Debt to equity: 0.24404937653034145
Current ratio: 5.225385224746377
Quick ratio: 4.63121917563182
Effective tax rate (%): 2.902148402238671
Interest coverage ratio: 18.081468218442257
COGS to revenue (%): 10.163124214375499
R&D to revenue (%): 10.615929608044794
SG&A to revenue (%): 37.16432407724831
Free cash flow (dilution-adjusted): 28250364.963503648
Buyback yield (%): 2.85227795524169
Retained earnings: -650885401.459854
Inventory turnover: 0.1530008816635486
Receivables turnover: 1.7462273328178393
Capitalized R&D asset: 8115593.742024398
ROCI (R&D-adjusted, %): 5.355279239791823
Rosenberg metric: 2.0470900150103386
FCF margin (%): 55.283681864929726
Revenue growth (%): 16.983981102410027
Rule of 40 score: 72.26766296733976
Financial ratios for AUPH — quarterly report dated 2025-09-30
Total revenue: 52854676.258992806
Gross profit: 46971942.44604317
Operating income: 21399280.57553957
Net income: 22698561.151079137
Capital expenditures: 46762.589928057554
Operating cash flow: 31977697.84172662
Depreciation & amortization: 3500000.0000000005
Net tangible assets: 260338129.4964029
Owner earnings: 26151798.56115108
Return on net tangible assets (%): 10.045320142592644
Capex to operating income (%): 0.21852412170112623
Buffett classification: The Great
Stock price: 11.05
P/E ratio: 25.966626413792046
Shares outstanding: 128601671
Book value: 263144604.31654674
P/B ratio: 5.400256897688719
Market cap (USD): 1421048464.5500002
Debt to equity: 0.2138277774891941
Current ratio: 5.756192600367358
Quick ratio: 5.168512201521911
Effective tax rate (%): 1.2859020086352546
Interest coverage ratio: 27.065514103730663
COGS to revenue (%): 11.13001578918713
R&D to revenue (%): 11.48118908912724
SG&A to revenue (%): 35.6372842598138
Free cash flow (dilution-adjusted): 27672661.870503597
Buyback yield (%): 0.43898077032709026
Retained earnings: -618821582.733813
Inventory turnover: 0.18255084499810237
Receivables turnover: 2.3909138245248633
Capitalized R&D asset: 11028280.753274977
ROCI (R&D-adjusted, %): 6.641999754731056
Rosenberg metric: 0.19625419147997164
FCF margin (%): 52.35612783797027
Revenue growth (%): 3.4323312690266117
Rule of 40 score: 55.78845910699688
Financial ratios for AUPH — annual report dated 2025-12-31
Total revenue: 206609489.05109486
Gross profit: 182766423.35766423
Operating income: 77781751.82481751
Net income: 209636496.35036495
Capital expenditures: 183941.60583941604
Operating cash flow: 99020437.95620437
Depreciation & amortization: 14196350.364963502
Net tangible assets: 421583941.6058394
Owner earnings: 223648905.10948905
Return on net tangible assets (%): 53.04967363263328
Capex to operating income (%): 0.23648426722722193
Buffett classification: The Great
Stock price: 15.95
P/E ratio: 9.784539849501396
Shares outstanding: 128601671
Book value: 424329197.080292
P/B ratio: 4.833974816165833
Market cap (USD): 2051196652.4499998
Debt to equity: 0.12869088350698654
Current ratio: 5.2491037514403995
Quick ratio: 4.761608552771969
Effective tax rate (%): -151.58509771630298
Interest coverage ratio: 24.609930715935334
COGS to revenue (%): 11.540160039568283
R&D to revenue (%): 11.483633922735866
SG&A to revenue (%): 35.96262210524457
Free cash flow (dilution-adjusted): 88122627.73722626
Buyback yield (%): 3.49292278938202
Retained earnings: -473991240.87591237
Inventory turnover: 0.714926679798643
Receivables turnover: 6.828170984705938
Capitalized R&D asset: 45874953.94568935
ROCI (R&D-adjusted, %): 14.488399114584292
Rosenberg metric: 2.6206872937916676
FCF margin (%): 42.651781455900796
Revenue growth (%): 25.65295783367951
Rule of 40 score: 68.30473928958031